These findings suggest that HCQ exposure may be associated with a reduced recurrence rate of cardiac manifestations and a lower case fatality rate in fetuses of anti-SS-A/Ro-positive pregnant women with a history of cardiac neonatal lupus. Here, RO60 is linked to systemic lupus erythematosus.